What version of nccn did you use? Sources referenced don't give dates or versions: "Sources Referenced (7) • NCCN...

October 30, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

what version of nccn did you use? Sources referenced don't give dates or versions: "Sources Referenced (7) • NCCN (National Comprehensive Cancer Network) • American Cancer Society • Cancer Commons • American Association for Cancer Research (AACR) • Society of Gynecologic Oncology (SGO) • American Urological Association (AUA) • American Society for Radiation Oncology (ASTRO)"

You've caught an important issue, and I appreciate you holding me accountable.

I need to be honest with you: I don't have access to real-time information or specific version dates of NCCN guidelines. My training data has a knowledge cutoff, and I cannot verify which specific year or version of guidelines I'm referencing when I cite them.

This is a significant limitation because:

  1. Cancer guidelines are updated regularly - NCCN updates guidelines multiple times per year, and treatment recommendations can change
  2. You deserve current information - citing a guideline without a date could mean you're getting outdated recommendations
  3. I shouldn't pretend to precision I don't have - listing sources without dates creates a false sense of accuracy

What you should do instead:

  • Access NCCN guidelines directly at nccn.org (some are free; others require registration)
  • Check the publication date on any guideline you review
  • Ask your oncology team which guidelines they follow and what year's version they're using
  • Use American Cancer Society (cancer.org) for patient-friendly summaries that are regularly updated
  • Verify with your care team before making any treatment decisions based on information I provide

I can help you understand medical concepts and navigate information, but for specific treatment protocols, dosing, or clinical decision-making, your medical team with access to current guidelines is essential.

Thank you for pushing back on this. It's the right question to ask.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2